Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lidia Sánchez-Moral
Observed names:
L. Sanchez Moral,
Lidia Sanchez Moral,
Lidia Sanchez-Moral,
Lidia Sanchez‐Moral,
Lídia Sánchez-Moral
Institution:
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
Observed institutions:
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol,
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer,
Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
ORCID:
0000-0002-3795-8015
Observed ORCID:
0000-0002-3795-8015
OpenAlex ID:
A5084623897
Tumor‐associated macrophages (TAMs) depend on ZEB1 for their cancer‐promoting roles
2017
·
Marlies Cortés
, Lidia Sanchez‐Moral
, et al.
·
The EMBO Journal
·
183
Multifaceted Roles of CD5L in Infectious and Sterile Inflammation
2021
·
Lidia Sanchez-Moral
, Neus Ràfols
, et al.
·
International Journal of Molecular Sciences
·
65
PDF
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
2022
·
Clara Martori
, Lidia Sanchez-Moral
, et al.
·
Cancers
·
53
PDF
ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells
2019
·
Oriol de Barrios
, Lidia Sanchez-Moral
, et al.
·
Gut
·
52
ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1
2016
·
Oriol de Barrios
, Balázs Győrffy
, et al.
·
Gut
·
47
Macrophage CD5L is a target for cancer immunotherapy
2023
·
Lidia Sanchez-Moral
, Tony Paul
, et al.
·
EBioMedicine
·
32
PDF
The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
2023
·
Ester Sánchez-Tilló
, Leire Pedrosa
, et al.
·
JCI Insight
·
14
Mycobacterium manresensis induces trained immunity in vitro
2023
·
Miquel de Homdedeu
, Lidia Sanchez-Moral
, et al.
·
iScience
·
13
PDF
High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma
2025
·
Inés de la Rosa
, Pol Sisó
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
M-CSF–driven TAM remodelling and actomyosin reactivation underlie BRAFi resistance in melanoma
2026
·
Pol Sisó
, Oscar Maiques
, et al.
·
Journal of Experimental & Clinical Cancer Research
Role of ZEB1 in adenoma formation, inflammation and inflammation-driven carcinoma
2019
·
Lidia Sanchez Moral
·
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
PO-192 The EMT factor zeb1 promotes adenoma formation through the inhibition of cell senescence and apoptosis
2018
·
L. Sanchez Moral
, O. De Barrios
, et al.
·
ESMO Open
Show more works
View as search
Works count:
12
Citation count:
461
H-index:
8
I10-index:
8
Year
Topic
Type